Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Manifestations of MR Activation in Primary Aldosteronism
NCT05030545Phase 4Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2022
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in primary aldosteronism (PA), sponsored by Brigham and Women's Hospital. Started Dec 2022; status: recruiting.
02
Drugs
eplerenone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT05030545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05030545.